Janney Montgomery Scott LLC Invests $479,000 in Acadia Healthcare Company, Inc. $ACHC

Janney Montgomery Scott LLC bought a new position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 21,111 shares of the company’s stock, valued at approximately $479,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. GAMMA Investing LLC increased its holdings in shares of Acadia Healthcare by 143.8% in the first quarter. GAMMA Investing LLC now owns 5,812 shares of the company’s stock worth $176,000 after buying an additional 3,428 shares during the period. Envestnet Portfolio Solutions Inc. purchased a new stake in Acadia Healthcare in the first quarter worth about $222,000. Teacher Retirement System of Texas purchased a new stake in Acadia Healthcare in the first quarter worth about $412,000. Palisade Capital Management LP lifted its holdings in Acadia Healthcare by 2.1% in the first quarter. Palisade Capital Management LP now owns 613,332 shares of the company’s stock worth $18,596,000 after buying an additional 12,807 shares during the period. Finally, Envestnet Asset Management Inc. increased its stake in shares of Acadia Healthcare by 8.2% during the first quarter. Envestnet Asset Management Inc. now owns 108,238 shares of the company’s stock valued at $3,282,000 after purchasing an additional 8,222 shares in the last quarter.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on ACHC. Royal Bank Of Canada decreased their target price on shares of Acadia Healthcare from $43.00 to $28.00 and set an “outperform” rating for the company in a research note on Wednesday, August 13th. Guggenheim cut their target price on shares of Acadia Healthcare from $36.00 to $29.00 and set a “buy” rating for the company in a research report on Thursday, August 7th. Mizuho dropped their price target on shares of Acadia Healthcare from $32.00 to $22.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 13th. Cowen reiterated a “buy” rating on shares of Acadia Healthcare in a research note on Thursday, August 7th. Finally, Cantor Fitzgerald restated a “neutral” rating and set a $25.00 target price on shares of Acadia Healthcare in a research note on Tuesday, October 7th. Eight research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Acadia Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $35.09.

Acadia Healthcare Stock Performance

Acadia Healthcare stock opened at $24.17 on Friday. The company has a market cap of $2.23 billion, a PE ratio of 16.01, a price-to-earnings-growth ratio of 4.90 and a beta of 0.90. Acadia Healthcare Company, Inc. has a twelve month low of $17.13 and a twelve month high of $60.52. The company’s 50-day moving average price is $23.11 and its 200-day moving average price is $23.23. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.73.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, beating the consensus estimate of $0.71 by $0.12. The company had revenue of $869.23 million for the quarter, compared to the consensus estimate of $839.59 million. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The firm’s revenue was up 9.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. On average, equities research analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.